Abstract
Severe veno-occlusive disease (VOD) of the liver is a leading cause of mortality after bone marrow transplantation (BMT). Vascular and parenchymal injuries account for acute portal hypertension and liver failure is frequently present. We describe the results of transjugular intrahepatic portosystemic shunt (TIPS) for the management of VOD after BMT. TIPS was performed in 10 patients with histologically proven severe VOD. Portal hypertension was controlled by TIPS in all patients (mean hepatic venous pressure gradient before, 20 ± 11 vs 6 ± 5 mm Hg after TIPS, P < 0.01) without technical complications. Five patients with rapidly worsening VOD died within 10 days of tips without any improvement. The five remaining patients with less advanced disease showed improvement in various clinical and biological parameters. Four patients subsequently died. The lone survivor continues to do well with resolution of VOD 6 months after tips. Tips can be performed safely and controls portal hypertension in VOD after BMT. Arguments from the present series and from eight previously reported cases favour earlier application of tips to obtain improved overall survival. Bone Marrow Transplantation (2000) 25, 987–992.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shulman HM, Hinterberger W . A review of the hepatic venoclusive disease: liver toxicity syndrome after bone marrow transplantation Bone Marrow Transplant 1992 10: 197–214
Jones RJ, Lee KSK, Beschorner WE et al. Venoocclusive disease of the liver following bone marrow transplantation Transplantation 1987 44: 778–783
DeLeve LD, McCuskey RS, Wang X et al. Characterization of a reproducible rat model of hepatic veno-occlusive disease Hepatology 1999 29: 1779–1791
Shulman HM, Fisher LB, Schoch HG et al. Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms Hepatology 1994 19: 1171–1180
Bearman SI, Anderson GL, Mori M et al. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation J Clin Oncol 1993 11: 1729–1736
McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 1993 118: 255–267
Carreras E, Granena A, Navasa M et al. Transjugular liver biopsy in BMT Bone Marrow Transplant 1993 11: 21–26
Shulman HM, McDonald GB . Transvenous liver biopsy (TVLB) and pressure measurements in bone marrow transplant (BMT) recipients Hepatology 1992 16: 148 (Abstr.)
Azoulay D, Castaing D, Bismuth H . Transjugular intrahepatic porto-systemic shunt: technique and pitfalls. In: Steichen FM, Welter R (eds). New Techniques in Surgery Quality Medical Publishing: St Louis 1994
Azoulay D, Castaing D, Dennison A et al. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study Hepatology 1994 19: 129–132
Levy V, Azoulay D, Rio B et al. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS) Bone Marrow Transplant 1996 18: 443–445
Henderson JM, Warren WD, Millikan WJ et al. Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome Am J Surg 1990 159: 41–48
Bismuth H, Sherlock D . Portasystemic shunting versus liver transplantation for the Budd–Chiari syndrome Ann Surg 1991 214: 581–589
Langnas AN, Sorrell MF . The Budd–Chiari syndrome: a therapeutic Gordian knot? Semin Liver Dis 1993 13: 352–359
Murray JA, LaBrecque DR, Gingrich RD et al. Successful treatment of hepatic venocclusive disease in a bone marrow transplant patient with a side-to-side portacaval shunt Gastroenterology 1987 92: 1073–1077
Jacobson BK, Kalayoglu M . Effective early treatment of hepatic venocclusive disease with central splenorenal shunt in an infant J Pediatr Surg 1992 27: 531–533
De la Rubia J, Carral A, Montes H et al. Successful treatment of hepatic veno-occlusive disease in a peripheral blood progenitor cell transplant patient with a transjugular intrahepatic portosystemic stent-shunt (TIPS) Haematologica 1996 81: 536–539
Smith FO, Johnson MS, Scherer LR et al. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease Bone Marrow Transplant 1996 18: 643–646
Fried MW, Connaghan DG, Martin LG et al. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation Hepatology 1996 24: 588–591
Rubenfeld GD, Crawford SW . Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines Ann Intern Med 1996 125: 625–633
Richardson PG, Elias AD, Krishnan A et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population Blood 1998 92: 737–744
Nimer SD, Milewicz AL, Champlin RE, Busuttil RW . Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation Transplantation 1990 49: 819–821
Rapoport AP, Doyle HR, Starzl T et al. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogenic bone marrow transplant Bone Marrow Transplant 1991 8: 421–424
Dowlati A, Honore P, Damas P et al. Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease of graft-versus-host disease following bone marrow transplantation Transplantation 1995 60: 106–108
Hägglund H, Ringdén O, Ericzon BG et al. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogenic bone marrow transplantation Transplantation 1996 62: 1076–1080
Rosen HR, Martin P, Schiller GJ et al. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease of the liver Liver Transplant Surg 1996 2: 225–232
Bunin N, Leahey A, Dunn S . Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation Transplantation 1996 61: 664–666
Norris S, Crosbie O, McEntee G et al. Orthotopic liver transplantation for veno-occlusive disease complicating autologous bone marrow transplantation Transplantation 1997 63: 1521–1524
Castells A, Salmeron JM, Navasa M et al. Liver transplantation for acute liver failure: analysis of applicability Gastroenterology 1993 105: 532–538
Ishitani M, Wilkowski M, Stevenson W, Pruett T . Outcome of patients requiring hemodialysis after liver transplantation Transplant Proc 1993 25: 1762–1763
Kuo PC, Johnson LB, Hastings G et al. Fulminant hepatic failure from the Budd–Chiari syndrome. A bridge to transplantation with transjugular intrahepatic portosystemic shunt Transplantation 1996 62: 294–296
Acknowledgements
We thank the Bone Marrow Transplant Centers from Saint Louis Hospital (Pr Gluckman, Paris), Hotel Dieu Hospital (Pr Zittoun, Paris), Henri Mondor Hospital (Pr Vernant, Créteil), and Institut Gustave Roussy (Dr Vincent, Dr Hartmann, Villejuif) for sending their patients to us.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Azoulay, D., Castaing, D., Lemoine, A. et al. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transplant 25, 987–992 (2000). https://doi.org/10.1038/sj.bmt.1702386
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702386
Keywords
This article is cited by
-
Interventional Radiology and Surgical Treatment Options for Non-Cirrhotic Portal Hypertension
Current Hepatology Reports (2023)
-
Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis
CardioVascular and Interventional Radiology (2023)
-
Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum
BMC Gastroenterology (2021)
-
Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt
Hepatology International (2021)
-
Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt
Hepatology International (2021)